Authors demonstrate the basic concepts and the application possibilities of transtelephonic ECG system in the clinical cardiological practice. The basic element of the system is a hand-size transducer that is capable to send ECG signals--through any telephone network to the Analysing Center. The application of system is very successful in the acute coronary syndrome, angina pectoris, dangerous arrhythmias and for home controlling of cardiac patients. They show the most important international results and their national system.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1556/OH.2007.28142 | DOI Listing |
Heart Rhythm
June 2024
McGill University Health Centre, Montreal, Quebec, Canada.
Background: Early recurrence of atrial tachyarrhythmias (ERAT) within 3 months of thermal ablation for atrial fibrillation (AF) is common and often considered transient. Pulsed field ablation (PFA) is a nonthermal energy source in which ERAT is not well described.
Objective: The purpose of this study was to analyze ERAT in patients with AF undergoing PFA in the Pulsed Field Ablation to Irreversibly Electroporate Tissue and Treat AF (PULSED AF) trial.
Heart Rhythm
August 2024
Icahn School of Medicine at Mount Sinai, New York, New York; Homolka Hospital, Prague, Czech Republic. Electronic address:
Background: During pulsed field ablation (PFA), electrode-tissue proximity optimizes lesion quality. A novel "single-shot" map-and-ablate spherical multielectrode PFA array catheter that is able to verify electrode-tissue contact was recently studied in a first-in-human trial of atrial fibrillation (AF).
Objective: The aim of this study was to report lesion durability data, safety, and 12-month effectiveness outcomes.
Europace
March 2024
Department of Cardiology, Nemocnice Na Homolce Hospital, Prague, Czech Republic.
Aims: Pulmonary vein isolation (PVI) is a well-established strategy for the treatment of paroxysmal atrial fibrillation (PAF). Despite randomized controlled trials and real-world data showing the promise of pulsed-field ablation (PFA) for this treatment, long-term efficacy and safety data demonstrating single-procedure outcomes off antiarrhythmic drugs remain limited. The aim of the FARA-Freedom Study was to evaluate the long-term efficacy and safety of PFA using the pentaspline catheter for PAF.
View Article and Find Full Text PDFCirculation
May 2023
Emory Heart & Vascular Center at St. Joseph's, Atlanta, GA (D.B.D.).
Background: Pulsed field ablation uses electrical pulses to cause nonthermal irreversible electroporation and induce cardiac cell death. Pulsed field ablation may have effectiveness comparable to traditional catheter ablation while preventing thermally mediated complications.
Methods: The PULSED AF pivotal study (Pulsed Field Ablation to Irreversibly Electroporate Tissue and Treat AF) was a prospective, global, multicenter, nonrandomized, paired single-arm study in which patients with paroxysmal (n=150) or persistent (n=150) symptomatic atrial fibrillation (AF) refractory to class I or III antiarrhythmic drugs were treated with pulsed field ablation.
Medicina (Kaunas)
April 2022
Department of Emergency Medicine and Disaster Medicine, Medical University of Lodz, 90-237 Lodz, Poland.
: The guidelines of the European Society of Cardiology (ESC) recommend the use of telematic methods in the diagnosis of myocardial infarction, allowing for transtelephonic electrocardiography (TTECG) from the emergency scene to centers performing percutaneous coronary interventions (PCI center). It has been proven that such a procedure has a beneficial effect on the survival of patients with ST elevation myocardial infarction (STEMI). Fewer data can be found on the correct use of these methods in everyday clinical practice.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!